Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bootsma

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Immunology|September 1, 1994
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective studyP E Spronk, H Bootsma, M G Huitema, et al.
Journal of Inherited Metabolic Disease|November 21, 2014
Principles and practice of lipidomicsFrédéric M Vaz, Mia Pras-Raves, Albert H Bootsma, et al.
Oral Diseases|March 9, 2016
The microbiome-systemic diseases connectionT A van der Meulen, Hjm Harmsen, H Bootsma, et al.
Lupus|November 24, 2006
Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosusK de Leeuw, B Freire, A J Smit, et al.
Diabetes Care|January 28, 2003
Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variantIngrid I L Berk-Planken, Nicoline Hoogerbrugge, Ronald P Stolk, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Genetic changes in somatostatin receptor positive breast tumorsA H Bootsma, A de Klein, J C Reubi, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximabP M Meiners, S Arends, E Brouwer, et al.
Epidemiology and Infection|February 1, 1995
Host-microflora interaction in systemic lupus erythematosus (SLE): circulating antibodies to the indigenous bacteria of the intestinal tractH Z Apperloo-Renkema, H Bootsma, B I Mulder, et al.
Rheumatology (Oxford, England)|February 7, 2001
Simultaneous presentation of sarcoidosis and Sjögren's syndromeA van de Loosdrecht, W Kalk, H Bootsma, et al.
Scandinavian Journal of Rheumatology|September 27, 2019
Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAIA Heus, S Arends, J F Van Nimwegen, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Immunology|September 1, 1994
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective studyP E Spronk, H Bootsma, M G Huitema, et al.
Journal of Inherited Metabolic Disease|November 21, 2014
Principles and practice of lipidomicsFrédéric M Vaz, Mia Pras-Raves, Albert H Bootsma, et al.
Oral Diseases|March 9, 2016
The microbiome-systemic diseases connectionT A van der Meulen, Hjm Harmsen, H Bootsma, et al.
Lupus|November 24, 2006
Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosusK de Leeuw, B Freire, A J Smit, et al.
Diabetes Care|January 28, 2003
Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variantIngrid I L Berk-Planken, Nicoline Hoogerbrugge, Ronald P Stolk, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Genetic changes in somatostatin receptor positive breast tumorsA H Bootsma, A de Klein, J C Reubi, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximabP M Meiners, S Arends, E Brouwer, et al.
Epidemiology and Infection|February 1, 1995
Host-microflora interaction in systemic lupus erythematosus (SLE): circulating antibodies to the indigenous bacteria of the intestinal tractH Z Apperloo-Renkema, H Bootsma, B I Mulder, et al.
Rheumatology (Oxford, England)|February 7, 2001
Simultaneous presentation of sarcoidosis and Sjögren's syndromeA van de Loosdrecht, W Kalk, H Bootsma, et al.
Scandinavian Journal of Rheumatology|September 27, 2019
Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAIA Heus, S Arends, J F Van Nimwegen, et al.
Pageof 11